Component
High-density lipoprotein particles; preparation specified
High-density lipoprotein particles; preparation specified. Species, exposure and limitations are retained in each linked claim.
5 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Adding HDL reduced cellular lutein in the HEK293 assay despite preferential retention relative to beta-carotene.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lutein-research/36863431.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "530dd42d442890be2e5cd11c18bf95c0bd850d8f67ad6682d12360dfc7f8aec0", "start_char": 0, "end_char": 1551, "text_sha256": "530dd42d442890be2e5cd11c18bf95c0bd850d8f67ad6682d12360dfc7f8aec0"}
- experimental_model
- SR-BI expression, tunnel mutation, binding and lipoprotein-partner assays
- exposure
- Wild-type or C384Y SR-BI; HDL and hepatic lipase additions
- limitations
- Engineered-cell mechanisms, not a clinical HDL-raising recommendation; no selective direct binding to lutein demonstrated.
- nutrient_topic
- Lutein research collection; topical membership is not evidence of a direct dietary effect. · Lutein
- organism
- Human HEK293 cell system
- plain_language
- More carrier did not simply mean more uptake in this assay.
- primary_references
- [lutein-p36863431] Mechanism for the selective uptake of macular carotenoids mediated by the HDL cholesterol receptor SR-BI. (2023). https://pubmed.ncbi.nlm.nih.gov/36863431/ DOI: 10.1016/j.exer.2023.109429
- tissue_or_cell_type
- Engineered cells without endogenous SR-BI
Lutein: metabolism, signaling and nutrient connections (2026-09-17) · lines 697–708
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · SR-BI expression, tunnel mutation, binding and lipoprotein-partner assays · source_derived_draft · unverified_draft
### lutein-hdl-cell-context Adding HDL reduced cellular lutein in the HEK293 assay despite preferential retention relative to beta-carotene. Condition category: normal nutrient_topic: Lutein research collection; topical membership is not evidence of a direct dietary effect. plain_language: More carrier did not simply mean more uptake in this assay. organism: Human HEK293 cell system tissue_or_cell_type: Engineered cells without endogenous SR-BI experimental_model: SR-BI expression, tunnel mutation, binding and lipoprotein-partner assays limitations: Engineered-cell mechanisms, not a clinical HDL-raising recommendation; no selective direct binding to lutein demonstrated. exposure: Wild-type or C384Y SR-BI; HDL and hepatic lipase additions evidence_span: {"source_cache": "artifacts/lutein-research/36863431.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "530dd42d442890be2e5cd11c18bf95c0bd850d8f67ad6682d12360dfc7f8aec0", "start_char": 0, "end_char": 1551, "text_sha256": "530dd42d442890be2e5cd11c18bf95c0bd850d8f67ad6682d12360dfc7f8aec0"} [lutein-p36863431] Mechanism for the selective uptake of macular carotenoids mediated by the HDL cholesterol receptor SR-BI. (2023). https://pubmed.ncbi.nlm.nih.gov/36863431/ DOI: 10.1016/j.exer.2023.109429
Complete structured claim and evidenceHDL most effectively delivered zeaxanthin and meso-zeaxanthin; SR-BI inhibition suppressed zeaxanthin delivery.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lutein-research/27538825.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1db014221931676349f15dc3c5138fba122417fb49fec5de481594c72b0596f3", "start_char": 0, "end_char": 1346, "text_sha256": "1db014221931676349f15dc3c5138fba122417fb49fec5de481594c72b0596f3"}
- experimental_model
- Carotenoid delivery using isolated human lipoproteins
- exposure
- Carotenoid-loaded LDL versus HDL
- limitations
- Cell delivery ranking is not identical to circulating carriage fractions or the WHAM-chicken phenotype.
- nutrient_topic
- Lutein research collection; topical membership is not evidence of a direct dietary effect. · Lutein
- organism
- Human ARPE-19 cells
- plain_language
- The preferred delivery route differed between pigments.
- primary_references
- [lutein-p27538825] Mechanisms of selective delivery of xanthophylls to retinal pigment epithelial cells by human lipoproteins. (2016). https://pubmed.ncbi.nlm.nih.gov/27538825/ DOI: 10.1194/jlr.m070193
- tissue_or_cell_type
- Retinal pigment epithelial model
Lutein: metabolism, signaling and nutrient connections (2026-09-17) · lines 645–656
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Carotenoid delivery using isolated human lipoproteins · source_derived_draft · unverified_draft
### lutein-hdl-z-delivery HDL most effectively delivered zeaxanthin and meso-zeaxanthin; SR-BI inhibition suppressed zeaxanthin delivery. Condition category: normal nutrient_topic: Lutein research collection; topical membership is not evidence of a direct dietary effect. plain_language: The preferred delivery route differed between pigments. organism: Human ARPE-19 cells tissue_or_cell_type: Retinal pigment epithelial model experimental_model: Carotenoid delivery using isolated human lipoproteins limitations: Cell delivery ranking is not identical to circulating carriage fractions or the WHAM-chicken phenotype. exposure: Carotenoid-loaded LDL versus HDL evidence_span: {"source_cache": "artifacts/lutein-research/27538825.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1db014221931676349f15dc3c5138fba122417fb49fec5de481594c72b0596f3", "start_char": 0, "end_char": 1346, "text_sha256": "1db014221931676349f15dc3c5138fba122417fb49fec5de481594c72b0596f3"} [lutein-p27538825] Mechanisms of selective delivery of xanthophylls to retinal pigment epithelial cells by human lipoproteins. (2016). https://pubmed.ncbi.nlm.nih.gov/27538825/ DOI: 10.1194/jlr.m070193
Complete structured claim and evidenceAfter the high-xanthophyll diet, HDL carried 52% of measured plasma lutein; LDL carried approximately 22%.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lutein-research/17344498.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "582744e7beef9ad8341bf862c9d344c1f188e6087676bcaa4c32679547fffe79", "start_char": 0, "end_char": 1666, "text_sha256": "582744e7beef9ad8341bf862c9d344c1f188e6087676bcaa4c32679547fffe79"}
- experimental_model
- Controlled low- then high-xanthophyll diet
- exposure
- About 1.1 mg/day L+Z for two weeks then 11 mg/day for four weeks
- limitations
- Small dietary study; circulating distribution is not retinal delivery or an intervention to raise HDL cholesterol.
- nutrient_topic
- Lutein research collection; topical membership is not evidence of a direct dietary effect. · Lutein
- organism
- Seven AMD patients and five controls
- plain_language
- Lutein traveled in more than one lipoprotein class.
- primary_references
- [lutein-p17344498] Effect of dietary lutein and zeaxanthin on plasma carotenoids and their transport in lipoproteins in age-related macular degeneration. (2007). https://pubmed.ncbi.nlm.nih.gov/17344498/ DOI: 10.1093/ajcn/85.3.762
- tissue_or_cell_type
- Plasma and separated lipoprotein fractions
Lutein: metabolism, signaling and nutrient connections (2026-09-17) · lines 619–630
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Controlled low- then high-xanthophyll diet · source_derived_draft · unverified_draft
### lutein-human-hdl-carriage After the high-xanthophyll diet, HDL carried 52% of measured plasma lutein; LDL carried approximately 22%. Condition category: normal nutrient_topic: Lutein research collection; topical membership is not evidence of a direct dietary effect. plain_language: Lutein traveled in more than one lipoprotein class. organism: Seven AMD patients and five controls tissue_or_cell_type: Plasma and separated lipoprotein fractions experimental_model: Controlled low- then high-xanthophyll diet limitations: Small dietary study; circulating distribution is not retinal delivery or an intervention to raise HDL cholesterol. exposure: About 1.1 mg/day L+Z for two weeks then 11 mg/day for four weeks evidence_span: {"source_cache": "artifacts/lutein-research/17344498.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "582744e7beef9ad8341bf862c9d344c1f188e6087676bcaa4c32679547fffe79", "start_char": 0, "end_char": 1666, "text_sha256": "582744e7beef9ad8341bf862c9d344c1f188e6087676bcaa4c32679547fffe79"} [lutein-p17344498] Effect of dietary lutein and zeaxanthin on plasma carotenoids and their transport in lipoproteins in age-related macular degeneration. (2007). https://pubmed.ncbi.nlm.nih.gov/17344498/ DOI: 10.1093/ajcn/85.3.762
Complete structured claim and evidenceHDL increased zeaxanthin uptake mediated by the tested SRB proteins.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/zeaxanthin-research/28947101.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "8899547af674d9bc7acc413d58c440726a1469ca705aa82bc5dafd5c89aadcc2", "start_char": 0, "end_char": 1330, "text_sha256": "8899547af674d9bc7acc413d58c440726a1469ca705aa82bc5dafd5c89aadcc2"}
- experimental_model
- SPR and transporter overexpression
- exposure
- SR-BI, SCARB2/LIMP-II and CD36; HDL or LDL carriers
- limitations
- The study used SCARB2/LIMP-II (methods reagent AF1966), not the similarly named SCARB1 splice variant SR-BII. Reagent identity: https://www.rndsystems.com/products/human-limpii-sr-b2-antibody_af1966 . Transporter overexpression is not an oral absorption trial.
- nutrient_topic
- Zeaxanthin research collection; topical membership is not evidence of a direct dietary effect. · Dietary (3R,3-prime-R)-zeaxanthin
- organism
- Human proteins in HEK-293T cells and donor eye tissue
- plain_language
- The carrier and receptor worked together in this model.
- primary_references
- [zeaxanthin-p28947101] All three human scavenger receptor class B proteins can bind and transport all three macular xanthophyll carotenoids. (2017). https://pubmed.ncbi.nlm.nih.gov/28947101/ DOI: 10.1016/j.abb.2017.09.013
- tissue_or_cell_type
- Recombinant receptors and HEK-293T cells
Zeaxanthin: metabolism, signaling and nutrient connections (2026-09-17) · lines 626–637
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · SPR and transporter overexpression · source_derived_draft · unverified_draft
### zeaxanthin-hdl-delivery HDL increased zeaxanthin uptake mediated by the tested SRB proteins. Condition category: normal nutrient_topic: Zeaxanthin research collection; topical membership is not evidence of a direct dietary effect. plain_language: The carrier and receptor worked together in this model. organism: Human proteins in HEK-293T cells and donor eye tissue tissue_or_cell_type: Recombinant receptors and HEK-293T cells experimental_model: SPR and transporter overexpression limitations: The study used SCARB2/LIMP-II (methods reagent AF1966), not the similarly named SCARB1 splice variant SR-BII. Reagent identity: https://www.rndsystems.com/products/human-limpii-sr-b2-antibody_af1966 . Transporter overexpression is not an oral absorption trial. exposure: SR-BI, SCARB2/LIMP-II and CD36; HDL or LDL carriers evidence_span: {"source_cache": "artifacts/zeaxanthin-research/28947101.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "8899547af674d9bc7acc413d58c440726a1469ca705aa82bc5dafd5c89aadcc2", "start_char": 0, "end_char": 1330, "text_sha256": "8899547af674d9bc7acc413d58c440726a1469ca705aa82bc5dafd5c89aadcc2"} [zeaxanthin-p28947101] All three human scavenger receptor class B proteins can bind and transport all three macular xanthophyll carotenoids. (2017). https://pubmed.ncbi.nlm.nih.gov/28947101/ DOI: 10.1016/j.abb.2017.09.013
Complete structured claim and evidence
Where it participates (unsigned role)
Astaxanthin appeared in chylomicron/VLDL-rich, LDL and HDL plasma fractions after the meal; transport was not confined to one lipoprotein class.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Same three-person single-dose study.
- limitations
- Distribution is not proof of delivery to a particular organ or entry across the human blood-brain barrier.
- nutrient_topic
- Astaxanthin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Astaxanthin
- plain_language
- Several blood lipid carriers transported it.
- primary_references
- Plasma appearance and distribution of astaxanthin E/Z and R/S isomers in plasma lipoproteins of men after single dose administration of astaxanthin. · 2000 · https://pubmed.ncbi.nlm.nih.gov/11120445/ · DOI 10.1016/s0955-2863(00)00104-2
Astaxanthin: transport, membrane chemistry, signaling and nutrient interactions (2026-09-19) · lines 78–84
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Same three-person single-dose study. · source_derived_draft · unverified_draft
## astaxanthin-lipoprotein-distribution Several blood lipid carriers transported it. Astaxanthin appeared in chylomicron/VLDL-rich, LDL and HDL plasma fractions after the meal; transport was not confined to one lipoprotein class. Model: Same three-person single-dose study. Limitations: Distribution is not proof of delivery to a particular organ or entry across the human blood-brain barrier. Evidence access: Primary abstract Plasma appearance and distribution of astaxanthin E/Z and R/S isomers in plasma lipoproteins of men after single dose administration of astaxanthin. · 2000 · https://pubmed.ncbi.nlm.nih.gov/11120445/ · DOI 10.1016/s0955-2863(00)00104-2
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.